Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Eigengene value of the blue module consisted of 794 genes was negatively associated with the BMD Z score (P = 0.00294), whereas that of the magenta module containing 199 genes showed a positive association (P = 0.000758) (Fig. 2 and Figure S2).Characteristics of subjects enrolled.Childhood asthmatics† (n = 32)Adult asthmatics‡ (n = 17)Gender, male (%)23 (71.9)6 (35.3)Age, year8.63 (1.93)60.11 (11.71)Smoking, yes (%)Not applicable3 (17.65)Body mass index, kg/m217.71 (3.21)23.72 (5.18)Vitamin D, ng/mL31.81 (9.97)14.71 (7.72)Tanner stage (%)I/II/III/IV/V24 (75.0)/6 (18.8)/1(3.1)/1 (3.1)Not applicableBaseline BMD Z-score−0.10 (2.23)Not availableEthnicity (%)Non-Hispanic white32 (100)0Asian017 (100)Cumulative dose of PD, mg1188.40 (608.05)3130.53 (1552.09)Final BMD Z-score−0.29 (0.81)−0.97 (1.37)Data indicate mean (Standard deviation); BMD, Bone mineral density; PD, Prednisone; †Characteristics measured at enrollment of the CAMP study except cumulative dose of prednisone and the final BMD Z-score; ‡Characteristics measured at enrollment of the present study.Co-expression modules identified in gene expression profiles of Sham-treated immortalized B cells from childhood asthmatics.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Dex-treated IBCs were used to measure in vitro perturbation of gene expressions by Dex.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Identification of a key gene module associated with glucocorticoid: induced derangement in bone mineral density in patients with asthma
Study design awaiting verification · Scientific Reports · 2019
Original publication title
Identification of a key gene module associated with glucocorticoid: induced derangement in bone mineral density in patients with asthma
© The Author(s) 2019
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Derangement in bone mineral density (BMD) caused by glucocorticoid is well-known. The present study aimed to find key biological pathways associated with low BMD after glucocorticoid treatment in asthmatics using gene expression profiles of peripheral blood cells. We utilized immortalized B cells (IBCs) from 32 childhood asthmatics after multiple oral glucocorticoid bursts and peripheral blood mononuclear cells (PBMCs) from 17 adult asthmatics after a long-term use of oral glucocorticoid. We searched co-expressed gene modules significantly related with the BMD Z score in childhood asthmatics and tested if these gene modules were preserved and significantly associated with the BMD Z score in adult asthmatics as well.
We identified a gene module composed of 199 genes significantly associated with low BMD in both childhood and adult asthmatics. The structure of this module was preserved across gene expression profiles. We found that the cellular metabolic pathway was significantly enriched in this module. Among 18 hub genes in this module, we postulated that 2 genes, CREBBP and EP300, contributed to low BMD following a literature review. A novel biologic pathway identified in this study highlighted a gene module and several genes as playing possible roles in the pathogenesis of glucocorticoid: induced derangement in BMD.
Authors’ abstract
Derangement in bone mineral density (BMD) caused by glucocorticoid is well-known. The present study aimed to find key biological pathways associated with low BMD after glucocorticoid treatment in asthmatics using gene expression profiles of peripheral blood cells. We utilized immortalized B cells (IBCs) from 32 childhood asthmatics after multiple oral glucocorticoid bursts and peripheral blood mononuclear cells (PBMCs) from 17 adult asthmatics after a long-term use of oral glucocorticoid. We searched co-expressed gene modules significantly related with the BMD Z score in childhood asthmatics and tested if these gene modules were preserved and significantly associated with the BMD Z score in adult asthmatics as well.
We identified a gene module composed of 199 genes significantly associated with low BMD in both childhood and adult asthmatics. The structure of this module was preserved across gene expression profiles. We found that the cellular metabolic pathway was significantly enriched in this module. Among 18 hub genes in this module, we postulated that 2 genes, CREBBP and EP300, contributed to low BMD following a literature review. A novel biologic pathway identified in this study highlighted a gene module and several genes as playing possible roles in the pathogenesis of glucocorticoid: induced derangement in BMD.
Publication and source details
Original title: Identification of a key gene module associated with glucocorticoid: induced derangement in bone mineral density in patients with asthma
Suh-Young Lee; Ha-Kyeong Won; Byung-Keun Kim; Sae-Hoon Kim; Yoon-Seok Chang; Sang-Heon Cho; H. William Kelly; Kelan G. Tantisira; Heung-Woo Park
Scientific Reports · 2019
© The Author(s) 2019https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Kangdong Sacred Heart Hospital Fund (2015-10)https://doi.org/10.13039/501100004332Seoul National University Hospital (SNUH)0420153010 (2015-1079)Park Heung-WooRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T18:10:31.045718+00:00
DOI: 10.1038/s41598-019-56656-9 · PMC6934743